Professor | Renxi Wang | Asia Growth Partners

	Upload Avatar (500 x 500)
Name	Renxi Wang
Contact Information	renxi_wang@ccmu.edu.cn
Language ability	English, Chinese
Province	Beijing

Upload Avatar (500 x 500)

Name

Renxi Wang

Contact Information

renxi_wang@ccmu.edu.cn

Language ability

English, Chinese

Province

Beijing

University/Lab Affiliation and Title	Capital Medical University
Faculty	Brain Disorders
Academic Background & Achievements	2010-2012: Postdoctor, Molecular Immunology, National Eye Institute, National Institute of Health, MD, USA 2009-2010: Postdoctor, Eppley Cancer Institute, Nebraska University Medical Center, NE, USA 2003-2006: Ph.D, Molecular Immunology, Beijing Institute of Basic Medical Sciences, Beijing, P.R. China 2000-2003: M.S, Molecular Immunology, Beijing Institute of Basic Medical Sciences, Beijing, P.R. China 1995-1999: B.S, Department of Biology, Henan Normal University, Henan, P.R. China
Work Experience	2019-present: Professor and lab director in Laboratory of Neuroimmunology, Beijing Institute of Brain Disorders, Capital Medical University 2014-2019: Associate Professor, Institute of Basic Medical Sciences, Beijing, P.R. China 2006-2014: Assistant Professor, Institute of Basic Medical Sciences, Beijing, P.R. China
Awards	National Natural Science Foundation of China (2021-2024, 550,000 yuan) Beijing Natural Science Foundation (2018-2020, 200,000 yuan)

University/Lab Affiliation and Title

Capital Medical University

Faculty

Brain Disorders

Academic Background & Achievements

2010-2012: Postdoctor, Molecular Immunology, National Eye Institute, National Institute of Health, MD, USA
2009-2010: Postdoctor, Eppley Cancer Institute, Nebraska University Medical Center, NE, USA
2003-2006: Ph.D, Molecular Immunology, Beijing Institute of Basic Medical Sciences, Beijing, P.R. China
2000-2003: M.S, Molecular Immunology, Beijing Institute of Basic Medical Sciences, Beijing, P.R. China
1995-1999: B.S, Department of Biology, Henan Normal University, Henan, P.R. China

Work Experience

2019-present: Professor and lab director in Laboratory of Neuroimmunology, Beijing Institute of Brain Disorders, Capital Medical University
2014-2019: Associate Professor, Institute of Basic Medical Sciences, Beijing, P.R. China
2006-2014: Assistant Professor, Institute of Basic Medical Sciences, Beijing, P.R. China

Awards

National Natural Science Foundation of China (2021-2024, 550,000 yuan)
Beijing Natural Science Foundation (2018-2020, 200,000 yuan)

Areas of Focus	Immunological mechanisms of major brain diseases Potential therapeutic targets for immune-related diseases
Publications	Gm40600 promotes CD4+T cell responses by interacting with Ahnak, He Y, Fang Y, Zhai B, Liu X, Zhu G, Zhou S, Xu Y, Wang X, Su W, Wang R, 2021 Peripheral Injection of Tim-3 Antibody Attenuates VSV Encephalitis by Enhancing MHC-I Presentation, Li G, Tang L, Hou C, Wang Z, Gao Y, Dou S, Mo R, Hao Y, Gao Z, Li Y, Dong J, Zhang J, Shen B, Wang R, Han G, 2021 Gm614 protects germinal center B cells from death by suppressing caspase-1 transcription in lupus-prone mice, He Y, Xu R, Zhai B, Zhou S, Wang X, Wang R, 2020 Hspa13 promotes plasma cell production and antibody secretion, He Y, Xu R, Zhai B, Fang Y, Hou C, Xing C, Xiao H, Chen G, Wang X, Ma N, Han G, Wang R, 2020 Post-transcriptional regulator Rbm47 elevates IL-10 production and promotes the immunosuppression of B cells, Wei Y, Zhang F, Zhang Y, Wang X, Xing C, Guo J, Zhang H, Suo Z, Li Y, Wang J, Wang R, Cai Z, 2019 Treatment of paraquat-induced lung injury with an anti-C5a antibody: potential clinical application, Sun S, Jiang Y, Wang R, Liu C, Liu X, Song N, Guo Y, Guo R, Du L, Jiang S, Li Y, Qiu Z, Zhao G, Zhou Y, 2018 Novel IL-23p19/Ebi3 (IL-39) Cytokine Mediates Inflammation in Lupus-like Mice, Wang X, Wei Y, Xiao H, Liu X, Zhang Y, Han G, Chen G, Hou C, Ma N, Shen B, Li Y, Wang R, 2016 Critical role for thymic CD19+CD5+CD1dhiIL-10+ regulatory B cells in immune homeostasis, Xing C, Ma N, Xiao H, Wang X, Zheng M, Han G, Chen G, Hou C, Shen B, Li Y, Wang R, 2015 BAFF Suppresses IL-15 Expression in B Cells, Ma N, Xing C, Xiao H, He Y, Han G, Chen G, Hou C, Marrero B, Wang Y, Zhang S, Shen B, Li Y, Wang R, 2014 Interleukin-35 induces regulatory B cells that suppress autoimmune disease, Wang RX, Yu CR, Dambuza IM, Mahdi RM, Dolinska M, Sergeey YV, Wingfield PT, Kim SH, Egwuagu CE, 2014

Areas of Focus

Immunological mechanisms of major brain diseases
Potential therapeutic targets for immune-related diseases

Publications

Gm40600 promotes CD4+T cell responses by interacting with Ahnak, He Y, Fang Y, Zhai B, Liu X, Zhu G, Zhou S, Xu Y, Wang X, Su W, Wang R, 2021
Peripheral Injection of Tim-3 Antibody Attenuates VSV Encephalitis by Enhancing MHC-I Presentation, Li G, Tang L, Hou C, Wang Z, Gao Y, Dou S, Mo R, Hao Y, Gao Z, Li Y, Dong J, Zhang J, Shen B, Wang R, Han G, 2021
Gm614 protects germinal center B cells from death by suppressing caspase-1 transcription in lupus-prone mice, He Y, Xu R, Zhai B, Zhou S, Wang X, Wang R, 2020
Hspa13 promotes plasma cell production and antibody secretion, He Y, Xu R, Zhai B, Fang Y, Hou C, Xing C, Xiao H, Chen G, Wang X, Ma N, Han G, Wang R, 2020
Post-transcriptional regulator Rbm47 elevates IL-10 production and promotes the immunosuppression of B cells, Wei Y, Zhang F, Zhang Y, Wang X, Xing C, Guo J, Zhang H, Suo Z, Li Y, Wang J, Wang R, Cai Z, 2019
Treatment of paraquat-induced lung injury with an anti-C5a antibody: potential clinical application, Sun S, Jiang Y, Wang R, Liu C, Liu X, Song N, Guo Y, Guo R, Du L, Jiang S, Li Y, Qiu Z, Zhao G, Zhou Y, 2018
Novel IL-23p19/Ebi3 (IL-39) Cytokine Mediates Inflammation in Lupus-like Mice, Wang X, Wei Y, Xiao H, Liu X, Zhang Y, Han G, Chen G, Hou C, Ma N, Shen B, Li Y, Wang R, 2016
Critical role for thymic CD19+CD5+CD1dhiIL-10+ regulatory B cells in immune homeostasis, Xing C, Ma N, Xiao H, Wang X, Zheng M, Han G, Chen G, Hou C, Shen B, Li Y, Wang R, 2015
BAFF Suppresses IL-15 Expression in B Cells, Ma N, Xing C, Xiao H, He Y, Han G, Chen G, Hou C, Marrero B, Wang Y, Zhang S, Shen B, Li Y, Wang R, 2014
Interleukin-35 induces regulatory B cells that suppress autoimmune disease, Wang RX, Yu CR, Dambuza IM, Mahdi RM, Dolinska M, Sergeey YV, Wingfield PT, Kim SH, Egwuagu CE, 2014

Immunology Brain Diseases Therapeutic Targets Cytokines Il-35 Regulatory B Cells Autoimmune Diseases Molecular Regulation Cell Differentiation Immune Homeostasis

Gaizhi Zhu - Capital Medical University

View All

Personal Information

Academic Information

Research

Contact us

No account yet?

Personal Information

Academic Information

Research

Contact us